fda semaglutide compounding enforcement november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA crackdown on off-brand Ozempic

SKU: 79331471864

Pay in 4 interest-free payments of $5.59 Learn more

Live Spec

FDA crackdown on off brand Ozempic products set to take effect, threatening supply and access for many CNN New project announcement: HHSOIG is taking a closer look at FDA's oversight of compounded GLP1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight loss and peptide products. An FDA warning letter to ProRx states the company continued FDA to Restrict Ingredients Used in Mass Marketed Compounded GLP 1s, Crack Down on Misleading Ads AJMC

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de